Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Edwards Lifesciences Corp (NYSE:EW)

124.51
Delayed Data
As of 4:01pm ET
 +0.60 / +0.48%
Today’s Change
86.55
Today|||52-Week Range
124.57
+10.47%
Year-to-Date
Patten & Patten Inc Buys KeyCorp, Texas Instruments Inc, UnitedHealth Group Inc, Sell...
10:38am / GuruFocus News - Paid Partner Content
Wendell David Associates Inc Buys iShares U.S. ...
Jan 16 / GuruFocus News - Paid Partner Content
Edwards Lifesciences' (EW) THVT Likely to Drive Q4 Earnings
9:19am / Zacks.com - Paid Partner Content
7 Quality Stocks in Gurus' Portfolios
Jan 16 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close123.91
Today’s open123.75
Day’s range123.19 - 124.57
Volume1,116,123
Average volume (3 months)1,461,954
Market cap$26.2B
Data as of 4:01pm ET, 01/22/2018

Growth & Valuation

Earnings growth (last year)+16.00%
Earnings growth (this year)+30.05%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+18.85%
P/E ratio36.3
Price/Sales6.89
Price/Book10.01

Competitors

 Today’s
change
Today’s
% change
SNNSmith & Nephew PLC+0.10+0.29%
ISRGIntuitive Surgical+0.71+0.16%
STESTERIS plc-0.11-0.12%
HRCHill-Rom Holdings In...-0.07-0.08%
Data as of 4:02pm ET, 01/22/2018

Financials

Next reporting dateFebruary 2, 2018
EPS forecast (this quarter)$0.91
Annual revenue (last year)$3.0B
Annual profit (last year)$569.5M
Net profit margin19.22%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Michael A. Mussallem
Chief Financial Officer &
Vice President
Scott B. Ullem
Corporate headquarters
Irvine, California

Forecasts